Missouri To Receive Part Of National Settlement With Opioid Treatment Drug Maker

Missouri will receive $1.8 million dollars of a nationwide $102.5 million dollars settlement with the opioid treatment drug maker Indivior.

The settlement stems from a complaint in 2016 signed on by 41 states alleging that Indivior used illegal means to switch the Suboxone market form tablets to film and attempted to destroy the market for the tablets in an effort to keep a drug monopoly. A trial on the complaint had been scheduled for September.

The agreement, which will be submitted to the court in the Eastern District of Pennsylvania for approval, requires Indivior to pay the states $102.5 million.

Indivior is also required to comply with negotiated injunctive terms of the agreement which include: disclosures to the States of all citizen petitions to the U.S. Food and Drug Administration, the introduction of new products, or if there is a change in corporate control. The terms ensure that Indivior refrains from engaging in the same kind of conduct alleged in the complaint.

Iowa was also one of the states receiving part of the settlement.